TCMD logo

Tactile Systems Technology, Inc. Stock Price

NasdaqGM:TCMD Community·US$541.2m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 24 Fair Values set on narratives written by author

TCMD Share Price Performance

US$23.93
7.99 (50.13%)
US$24.00
Fair Value
US$23.93
7.99 (50.13%)
0.3% undervalued intrinsic discount
US$24.00
Fair Value
Price US$23.93
AnalystConsensusTarget US$24.00

TCMD Community Narratives

AnalystConsensusTarget·
Fair Value US$24 0.3% undervalued intrinsic discount

TCMD: Market Leadership And Coverage Momentum Will Drive Expansion Into Underserved Patients

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative

Updated Narratives

TCMD logo

TCMD: Market Leadership And Coverage Momentum Will Drive Expansion Into Underserved Patients

Fair Value: US$24 0.3% undervalued intrinsic discount
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with proven track record.

1 Risk
3 Rewards

Tactile Systems Technology, Inc. Key Details

US$311.5m

Revenue

US$78.0m

Cost of Revenue

US$233.5m

Gross Profit

US$215.3m

Other Expenses

US$18.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.81
74.96%
5.83%
0%
View Full Analysis

About TCMD

Founded
1995
Employees
1037
CEO
Sheri Dodd
WebsiteView website
tactilemedical.com

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Recent TCMD News & Updates

Results: Tactile Systems Technology, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Nov 06
Results: Tactile Systems Technology, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Recent updates

No updates